U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Medical Products and Tobacco
  5. Center for Drug Evaluation and Research | CDER
  6. Office of Oncologic Diseases (OOD): Immediate Office
  1. Center for Drug Evaluation and Research | CDER

Office of Oncologic Diseases (OOD): Immediate Office

The Office of New Drugs is undergoing a reorganization. This site may be updated in the near future. Please check back often. For more information, please visit Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality.

Office Director (Acting): Richard Pazdur, MD
Regulatory Information Specialist: Bertha Mejia
Deputy Director (Acting): Marc R. Theoret, MD
Supervisory Associate Director (Acting): Gideon Blumenthal, MD
Supervisory Associate Director (Acting): Paul G. Kluetz, MD
Supervisory Associate Director for Regulatory Affairs (Acting): Tamy Kim, PharmD
Supervisory Associate Director for Safety (Acting):  Meredith Chuck, MD

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Oncology Drug Products
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone:  (301) 796-2340
Fax: (301) 796-9909

Resources For You